Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison

  • EK Vanhoutte
  • , THP Draak
  • , KC Gorson
  • , Sonja Nes
  • , JGJ (Janneke) Hoeijmakers
  • , WL van der Pol
  • , NC Notermans
  • , RA Lewis
  • , E Nobile-Orazio
  • , JM Leger
  • , PYK Van den Bergh
  • , G Lauria
  • , V Bril
  • , H Katzberg
  • , MPT Lunn
  • , J Pouget
  • , AJ van der Kooi
  • , AF Hahn
  • , Pieter van Doorn
  • , DR Cornblath
  • LH van den Berg, CG Faber, ISJ (Ingemar) Merkies

Research output: Contribution to journalArticleAcademic

41 Citations (Scopus)

Abstract

This study aimed to define responder' through the concept of minimum clinically important differences using the individually obtained standard errors (MCID-SE) and a heuristic external criterion' responsiveness method in patients with Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). One hundred and fourteen newly diagnosed or relapsing patients (GBS: 55, CIDP: 59) were serially examined (1-year follow-up). The inflammatory Rasch-built overall disability scale (I-RODS), Rasch-transformed MRC sum score (RT-MRC), and Rasch-transformed modified-INCAT-sensory scale (RT-mISS) were assessed. Being-a-responder was defined as having a MCID-SE cut-off 1.96. Also, the correlations between patients' scores on each scale and the EuroQoL health-status thermometer' (external criterion) were determined (higher correlation indicated better responsiveness). In both diseases, the SEs showed a characteristic U'-shaped dynamic pattern across each scales' continuum. The number of patients showing a meaningful change were higher for the I-RODS>RT-MRC>RT-mISS and were in GBS higher than CIDP patients. The MCID-SE concept using Rasch-transformed data demonstrated an individual pattern of being-a-responder' in patients with immune-mediated neuropathies, and the findings were validated by the external criterion responsiveness method. The I-RODS showed greater responsiveness compared with the MRC and INCAT-sensory scales, and its use is therefore recommended in future trials in GBS and CIDP.
Original languageUndefined/Unknown
Pages (from-to)289-295
Number of pages7
JournalJournal of the Peripheral Nervous System
Volume20
Issue number3
Publication statusPublished - 2015

Research programs

  • EMC MM-04-44-02

Cite this